美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA213279"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
55150-345-10 55150-345 HUMAN PRESCRIPTION DRUG Naloxone Hydrochloride Naloxone Hydrochloride INJECTION, SOLUTION INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS 20210114 N/A ANDA ANDA213279 Eugia US LLC NALOXONE HYDROCHLORIDE 1 mg/mL 10 SYRINGE in 1 BOX (55150-345-10) / 2 mL in 1 SYRINGE
55150-345-01 55150-345 HUMAN PRESCRIPTION DRUG Naloxone Hydrochloride Naloxone Hydrochloride INJECTION, SOLUTION INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS 20210114 N/A ANDA ANDA213279 Eugia US LLC NALOXONE HYDROCHLORIDE 1 mg/mL 1 SYRINGE in 1 BOX (55150-345-01) / 2 mL in 1 SYRINGE
51662-1586-3 51662-1586 HUMAN PRESCRIPTION DRUG NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTION, SOLUTION INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS 20220816 N/A ANDA ANDA213279 HF Acquisition Co LLC, DBA HealthFirst NALOXONE HYDROCHLORIDE 1 mg/mL 10 POUCH in 1 CASE (51662-1586-3) / 1 BOX in 1 POUCH (51662-1586-2) / 1 SYRINGE in 1 BOX / 2 mL in 1 SYRINGE
51662-1586-1 51662-1586 HUMAN PRESCRIPTION DRUG NALOXONE HYDROCHLORIDE NALOXONE HYDROCHLORIDE INJECTION, SOLUTION INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS 20220816 N/A ANDA ANDA213279 HF Acquisition Co LLC, DBA HealthFirst NALOXONE HYDROCHLORIDE 1 mg/mL 1 SYRINGE in 1 BOX (51662-1586-1) / 2 mL in 1 SYRINGE
71872-7299-1 71872-7299 HUMAN PRESCRIPTION DRUG Naloxone Hydrochloride Naloxone Hydrochloride INJECTION, SOLUTION INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS 20230125 N/A ANDA ANDA213279 Medical Purchasing Solutions, LLC NALOXONE HYDROCHLORIDE 1 mg/mL 1 SYRINGE in 1 BAG (71872-7299-1) / 2 mL in 1 SYRINGE
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase